Tevogen Bio Holdings Inc WT (TVGNW)

$0.09 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -70,000.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 15,763
Avg Vol 97,508
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 82%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 pat...

Phone: 877 838 6434
Website: tevogen.com
Address:
15 Independence Boulevard, Suite #210, Warren, United States
Latest News on TVGNW
No data available.